Concepedia

Iris de Weerdt

ID

8

Publications

641

Citations

8

H-Index

2014

Active since

Affiliations

Amsterdam University Medical Centers(Current)

University of Amsterdam

Albert Schweitzer Ziekenhuis

Vrije Universiteit Amsterdam

Leiden University Medical Center

Iris de Weerdt is an author at Amsterdam University Medical Centers specializing in medicine, hematology, and immunology.

Top concepts

Publications per year

2014–2023

8

Publications

8

Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study

Jan A. Burger, Michael J. Keating, William G. Wierda et al. · The Lancet Oncology · 2014 · 330 citations · Full text

, , +8

Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment

Iris de Weerdt, Tom Hofland, Renate de Boer et al. · Blood Advances · 2019 · 105 citations · Full text

A Bispecific Single-Domain Antibody Boosts Autologous Vγ9Vδ2-T Cell Responses Toward CD1d in Chronic Lymphocytic Leukemia

Iris de Weerdt, Roeland Lameris, Jurjen M. Ruben et al. · Clinical Cancer Research · 2021 · 52 citations · Full text

Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib

Iris de Weerdt, Tom Hofland, Roeland Lameris et al. · Blood · 2018 · 48 citations · Full text

A Bispecific Antibody Antagonizes Prosurvival CD40 Signaling and Promotes Vγ9Vδ2 T cell–Mediated Antitumor Responses in Human B-cell Malignancies

Iris de Weerdt, Roeland Lameris, George L. Scheffer et al. · Cancer Immunology Research · 2020 · 38 citations · Full text

Rows per page

1–5 of 8